FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
mskcc.org
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist ...
Aug 5, 2022
Trastuzumab Side Effects
Managing side effects in prolonged treatment with trastuzumab deruxtecan
0:38
Managing side effects in prolonged treatment with trastuzumab deruxtecan
YouTubeVJOncology
327 viewsOct 11, 2024
Trastuzumab Deruxtecan Side Effects: ILD - 2025 Patient Education Ambassadors Program
9:44
Trastuzumab Deruxtecan Side Effects: ILD - 2025 Patient Education Ambassadors Program
YouTubeGlobal Resource for
99 views7 months ago
Trastuzumab Deruxtecan's Impressive CR Rates & Managing Side Effects
1:10
Trastuzumab Deruxtecan's Impressive CR Rates & Managing Side Effects
YouTubeThe Oncology Brief
30 views2 months ago
Top videos
Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Breast Cancer (mBC) | OncLive
Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Breast Cancer (mBC) | OncLive
onclive.com
1 month ago
1.7K views · 26 reactions | What promises do biosimilar products offer? Watch this video with FDA Commissioner Dr. Scott Gottlieb and Dr. Leah Christl to learn more. https://go.usa.gov/xQyRZ | U.S. Food and Drug Administration | Facebook
0:14
1.7K views · 26 reactions | What promises do biosimilar products offer? Watch this video with FDA Commissioner Dr. Scott Gottlieb and Dr. Leah Christl to learn more. https://go.usa.gov/xQyRZ | U.S. Food and Drug Administration | Facebook
FacebookU.S. Food and Drug
1.7K views2 weeks ago
Biosimilars: Approval Process
2:47
Biosimilars: Approval Process
YouTubeU.S. Food and Drug
11.7K viewsDec 17, 2021
Trastuzumab Mechanism of Action
Mechanism of Action: Herceptin (Trastuzumab) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Mechanism of Action: Herceptin (Trastuzumab) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
targetedonc.com
Jun 29, 2013
Trastuzumab Deruxtecan in HER2+ Breast Cancer
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
YouTubeTargeted Oncology
503 viewsJul 7, 2020
Mechanism of Action | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
5:07
Mechanism of Action | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
enhertuhcp.com
May 26, 2020
Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Breast Cancer (mBC) | OncLive
Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Br…
1 month ago
onclive.com
1.7K views · 26 reactions | What promises do biosimilar products offer? Watch this video with FDA Commissioner Dr. Scott Gottlieb and Dr. Leah Christl to learn more. https://go.usa.gov/xQyRZ | U.S. Food and Drug Administration | Facebook
0:14
1.7K views · 26 reactions | What promises do biosimilar products o…
1.7K views2 weeks ago
FacebookU.S. Food and Drug Administration
Biosimilars: Approval Process
2:47
Biosimilars: Approval Process
11.7K viewsDec 17, 2021
YouTubeU.S. Food and Drug Administration
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilar…
Oct 27, 2018
onclive.com
Dr. Hurvitz on FDA Approval of Subcutaneous Trastuzumab Formulation in HER2+ Breast Cancer
1:00
Dr. Hurvitz on FDA Approval of Subcutaneous Trastuzumab Form…
1.5K viewsMar 8, 2019
YouTubeOncLive
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
3:50
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
44.6K viewsOct 21, 2015
YouTubeOncology Associates
Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancers │ Pharmacology
3:45
Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancer…
3.4K viewsAug 5, 2024
YouTubePharmacology Insights
Dr. Kolberg on Collecting Real-World Biosimilar Trastuzumab Dat…
Sep 4, 2019
onclive.com
Trastuzumab deruxtecan versus trastuzumab emtansine in patient…
6 days ago
onclive.com
7:44
Treatment Options for HER2+ Breast Cancer: A Comprehensive Guide …
15.4K viewsAug 16, 2024
YouTubeYerbba – Breast Cancer
1:20
Dr. Esteva on the Impact of the Trastuzumab Biosimilar Approval
242 viewsJul 6, 2018
YouTubeOncLive
Dr. Hurvitz on Biosimilars in Breast Cancer | OncLive
Apr 23, 2018
onclive.com
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Aug 23, 2019
onclive.com
1:45
What is a Biosimilar? - Video Explainer
10.1K viewsMar 16, 2023
YouTubeEuropean Medicines Agency
2:12
Trastuzumab Deruxtecan in HER2-Low Advanced Breast Cancer | NE…
10.3K viewsJul 7, 2022
YouTubeNEJM Group
6:48
Pertuzumab adds 16 months survival to trastuzumab plus chem…
962 viewsNov 11, 2014
YouTubeecancer
3:32
ENHERTU: Breakthrough Hope for HER2 Positive Cancers
50.2K viewsSep 2, 2023
YouTubePharma News & Analysis
Trastuzumab Deruxtecan for HER2+ Breast Cancer
8.4K viewsMar 27, 2018
YouTubeOncLive
5:59
Trastuzumab Deruxtecan for the Treatment of HER2+ Breast Cancer
3.5K viewsDec 24, 2019
YouTubeTargeted Oncology
What is a biosimilar? What is interchangeability? | The Biosimil…
Nov 15, 2019
biosimilarscouncil.org
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
503 viewsJul 7, 2020
YouTubeTargeted Oncology
9:19
#Trastuzumab | Uses, Dosage, Side Effects and Mechanism | Herceptin
3.3K viewsSep 9, 2023
YouTubeHe-InFo
3:43
Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low …
3.7K viewsJan 30, 2020
YouTubeOncLive
4:01
Trastuzumab deruxtecan: a promising agent for treating HER…
1.7K viewsMay 5, 2021
YouTubeVJOncology
5:26
Trastuzumab deruxtecan shows benefit in patients with HER2 + mBC
816 viewsMay 17, 2023
YouTubeecancer
7:45
Trastuzumab Emtansine in HER2+ Breast Cancer
1.7K viewsJul 7, 2020
YouTubeTargeted Oncology
Precision medicine and personalized breast cancer: combi…
Nov 1, 2024
nih.gov
4:31
FDA D.I.S.C.O. Burst Edition: FDA approval of Enhertu (fam-trastuzu…
530 viewsApr 2, 2024
YouTubeU.S. Food and Drug Administration
3:37
How Perjeta (Pertuzumab) is Used to Treat HER2-Positive Breast Cancer
15.6K viewsOct 27, 2017
YouTubeLighter Side of Cancer
See more videos
Static thumbnail place holder